StockData
Arvinas, Inc. logo

Arvinas, Inc. (ARVN) stock

ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.82+0.05 (+0.74%)

Close on Nov 17, 2026Market cap $445.93MP/E 42.6Yield –

Earnings

Arvinas's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$500.00K
-98.8% on a year earlier
EPS, Q3 FY2026
-$0.82
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Arvinas's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open$500.00K-98.8%-$0.82Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026before the open$249.70M+1014.7%$2.58Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open$15.60M-91.7%-$0.90Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026before the open$9.50M-84.0%-$1.10Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open$41.90M-59.1%–Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$22.40M-70.7%-$0.84Release
Q1 FY2025ended Mar 31, 2025May 1, 2025before the open$188.80M+646.2%$1.14Release
Q4 FY2024ended Dec 31, 2024Feb 11, 2025before the open$59.20M–-$0.63Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024before the open$102.40M+196.0%–Release
Q2 FY2024ended Jun 30, 2024Jul 30, 2024before the open$76.50M+40.4%-$0.49Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$25.30M-22.2%-$0.97Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Arvinas has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Arvinas puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Arvinas filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Update
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Update
  11. Results
  12. Update
  13. Update
  14. Update
  15. Update

See a number that looks wrong?